Atnaujinkite slapukų nuostatas

El. knyga: Mass Spectrometry for Drug Discovery and Drug Development

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Facilitates the discovery and development of new, effective therapeutics

With coverage of the latest mass spectrometry technology, this book explains how mass spectrometry can be used to enhance almost all phases of drug discovery and drug development, including new and emerging applications. The book's fifteen chapters have been written by leading pharmaceutical and analytical scientists. Their contributions are based on a thorough review of the current literature as well as their own experience developing new mass spectrometry techniques to improve the ability to discover and develop new and effective therapeutics.

Mass Spectrometry for Drug Discovery and Drug Development begins with an overview of the types of mass spectrometers that facilitate drug discovery and development. Next it covers:

  • HPLC high-resolution mass spectrometry for quantitative assays
  • Mass spectrometry for siRNA
  • Quantitative analysis of peptides
  • Mass spectrometry analysis of biological drugs
  • Applications that support medicinal chemistry investigations
  • Mass spectrometry imaging and profiling

Throughout the book, detailed examples underscore the growing role of mass spectrometry throughout the drug discovery and development process. In addition, images of mass spectra are provided to explain how results are interpreted. Extensive references at the end of each chapter guide readers to the primary literature in the field.

Mass Spectrometry for Drug Discovery and Drug Development is recommended for readers in pharmaceutics, including medicinal chemists, analytical chemists, and drug metabolism scientists. All readers will discover how mass spectrometry can streamline and advance new drug discovery and development efforts.

Contributors ix
Preface xi
1 Overview of the Various Types of Mass Spectrometers that are Used in Drug Discovery and Drug Development
1(36)
Gerard Hopfgartner
2 Utility of High-Resolution Mass Spectrometry for New Drug Discovery Applications
37(18)
William Bart Emary
Nanyan Rena Zhang
3 Quantitative Mass Spectrometry Considerations in a Regulated Environment
55(42)
Mohammed Jemal
Yuan-Qing Xia
4 Mass Spectrometry for Quantitative In Vitro ADME Assays
97(18)
Jun Zhang
Wilson Z. Shou
5 Metabolite Identification Using Mass Spectrometry in Drug Development
115(34)
Natalia Power
Joanna Zgoda-Pols
Chandra Prakash
6 MS Analysis of Biological Drugs, Proteins, and Peptides
149(42)
Yi Du
John Mehl
Pavlo Pristatsky
7 Characterization of Impurities and Degradation Products in Small Molecule Pharmaceuticals and Biologics
191(30)
Hui Wei
Guodong Chen
Adrienne A. Tymiak
8 Liquid Extraction Surface Analysis (LESA): A New Mass Spectrometry-Based Technique for Ambient Surface Profiling
221(18)
Daniel Eikel
Jack D. Henion
9 MS Applications in Support of Medicinal Chemistry Sciences
239(38)
Maarten Honing
Benno Ingelse
Birendra N. Pramanik
10 Imaging Mass Spectrometry of Proteins and Peptides
277(26)
Michelle L. Reyzer
Richard M. Caprioli
11 Imaging Mass Spectrometry for Drugs and Metabolites
303(36)
Stacey R. Oppenheimer
12 Screening Reactive Metabolites: Role of Liquid Chromatography-High-Resolution Mass Spectrometry in Combination with "Intelligent" Data Mining Tools
339(18)
Shuguang Ma
Swapan K. Chowdhury
13 Mass Spectrometry of siRNA
357(30)
Mark T. Cancilla
W. Michael Flanagan
14 Mass Spectrometry for Metabolomics
387(16)
Petia Shipkova
Michael D. Reily
15 Quantitative Analysis of Peptides with Mass Spectrometry: Selected Reaction Monitoring or High-Resolution Full Scan?
403(24)
Lieve Dillen
Filip Cuyckens
Index 427
WALTER A. KORFMACHER, PhD, is Director of Bioanalysis at Genzyme, a Sanofi company, and Associate Editor at the Journal of Mass Spectrometry. Previously, he held positions at the FDA's National Center for Toxicological Research, Schering-Plough Research Institute, Merck Research Laboratories, and Medpace Bioanalytical Laboratories. Dr. Korfmacher is an international leader in developing mass spectrometry techniques and strategies for new drug discovery and drug metabolism applications. A 2009 recipient of the CPSA Distinguished Analytical Scientist Award, he has published more than 150 articles in the scientific literature and made more than eighty presentations at various scientific forums.